Maternal PUFA status and offspring allergic diseases up to the age of 18 months

Area of Science:

• Nutritional Immunology
• Pediatric Allergy
• Reproductive Health

Background:

• Maternal polyunsaturated fatty acid (PUFA) status during pregnancy is hypothesized to influence early childhood allergic diseases.
• Existing research presents inconsistent findings regarding this association.
• Investigating this relationship in diverse ethnic cohorts is crucial for understanding allergy development.

Purpose of the Study:

• To examine the association between maternal PUFA status and the risk of allergic diseases in early childhood.
• To determine if maternal n-3 and n-6 PUFA levels during gestation predict offspring allergic outcomes.
• To explore the role of the n-6:n-3 PUFA ratio in early-life allergy development.

Main Methods:

• Maternal plasma PUFA levels were measured during pregnancy in an Asian mother-offspring cohort.
• Offspring were monitored from birth to 18 months for allergic diseases (rhinitis, eczema, wheezing) via questionnaires.
• Clinical assessments included skin prick testing (SPT) at 18 months to define allergic disease presence.

Main Results:

• Maternal total n-3 PUFA, n-6 PUFA, and the n-6:n-3 PUFA ratio showed no significant association with offspring rhinitis, eczema, wheezing, or positive SPT.
• A slight, non-significant trend suggested higher maternal n-3 PUFA might correlate with an increased risk of allergic diseases with positive SPT.
• The prevalence of positive SPT, rhinitis, eczema, and wheezing in offspring was reported.

Conclusions:

• Maternal PUFA status during pregnancy does not appear to significantly modify the risk of developing allergic diseases in early childhood within this Asian population.
• The findings do not support the hypothesis that maternal n-3 and n-6 PUFA levels are key determinants of early-life allergy.
• Further research may be needed to explore other nutritional or environmental factors influencing pediatric allergies.